OncoZenge Announces Dr. Paolo Bossi as New Member of the Advisory Board
Stockholm, Sweden – April 8 2024 – OncoZenge AB (publ), a leading pharmaceutical company developing BupiZenge™, an innovative, non-opioid treatment for oral pain, today announces that Dr. Paolo Bossi joins its Advisory Board.
Dela artikeln
Taggar: oncozenge, announces, paolo
Läs vidare på Dagens Industri